ga('send', 'pageview'); --}
REVIAN Hair Growth System
Dermatology San Antonio is now a certified REVIAN partner which allows us to recommend the next wave in hair restoration treatment options. REVIAN® RED is the first and only FDA-cleared, all-LED hair loss treatment for at-home use. It’s simple, safe, indicated for both men and women, and it grows hair.
Through their clinical trials, REVIAN has proven to stop hair loss and grow more hair with 10-minute, once daily treatments. As a partner, we are able to offer our patients a large discount off the regular retail price. You can learn more about the product and ORDER AT REVIAN.COM. To get the best internet price available, simply use the following coupon code at checkout: “DSAREVIAN”. If you’d like to discuss whether REVIAN RED is right for you, we will be happy to answer any questions you may have.
● Androgenetic alopecia is the most common type of alopecia in men and women.
● Women are an underserved patient population, especially those with post-partum and peri-menopausal hair loss.
● REVIAN RED works in both men and women.
● REVIAN RED is the first and only dual-wavelength, all LED light device that provides uniform scalp coverage.
● By increasing nitric oxide production, REVIAN RED stimulates the body's natural processes to rejuvenate hair and skin.
● The dual wavelength light in REVIAN RED is a patented method of releasing and regenerating nitric oxide stores on a daily basis.
● REVIAN RED stimulates nitric oxide, which targets all 3 pathogenic factors known to be involved in hair loss: 1) Reduces inflammation, 2) Acts as a vasodilator, 3) Inhibits 5-alpha reductase.
● REVIAN RED is an FDA-cleared medical device for use at home.
● REVIAN RED utilizes LED light and a mobile app for a technologically advanced hair growth experience.
● REVIAN RED does not interfere with any treatments the patient may be currently using.
● In a randomized, controlled trial involving 81 individuals with androgenetic alopecia, no REVIAN RED users reported any serious adverse events.